137
Views
0
CrossRef citations to date
0
Altmetric
Letter

Comparable outcome after related or unrelated allogeneic stem cell transplant following reduced conditioning with fludarabine, busulfan and antithymocyte globulin

, , , , , , , , , , , & show all
Pages 162-165 | Received 23 Jun 2011, Accepted 08 Jul 2011, Published online: 18 Aug 2011

References

  • Yakoub-Agha I, Mesnil F, Kuentz M, . Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy. J Clin Oncol 2006;24: 5695–5702.
  • Walter RB, Pagel JM, Gooley TA, . Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission. Leukemia 2010;24:1276–1282.
  • Moore J, Nivison-Smith I, Goh K, . Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia. Biol Blood Marrow Transplant 2007;13:601–607.
  • Weisdorf DJ, Anasetti C, Antin JH, . Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation. Blood 2002;99:1971–1977.
  • Kiehl MG, Kraut L, Schwerdtfeger R, . Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission. J Clin Oncol 2004;22:2816–2825.
  • Ottinger HD, Ferencik S, Beelen DW, . Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors. Blood 2003;102:1131–1137.
  • Slavin S, Nagler A, Naparstek E, . Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998;91: 756–763.
  • Glucksberg H, Storb R, Fefer A, . Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974;18:295–304.
  • Schulman HM, Sullivan KM, Weiden PL, . Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204–217.
  • Mielcarek M, Storer BE, Sandmaier BM, . Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors. Biol Blood Marrow Transplant 2007;13:1499–1507.
  • Uzunel M, Remberger M, Sairafi D, . Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning. Transplantation 2006;82:913–919.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.